The global ureteroscopy devices market is set to experience significant growth between 2024 and 2028, with an expected market increase of USD 297.8 million at a compound annual growth rate (CAGR) of 5.36%. This growth trajectory is driven by a combination of factors, including the rising prevalence of urolithiasis (kidney stones) and ureteral cancer, technological advancements in ureteroscopy devices, and the ongoing push for minimally invasive procedures.
For more details about the industry, get the PDF sample report for free
North America is expected to be the dominant region in the ureteroscopy devices market, contributing approximately 43% to the market's overall growth between 2024 and 2028. The United States, in particular, is a major player in this sector, driven by the high prevalence of kidney disease and the increasing demand for minimally invasive surgical procedures.
According to the CDC, over 6 million adults in the US were diagnosed with kidney disease in 2018. As a result, ureteroscopy procedures, which are widely used for the diagnosis and treatment of conditions like kidney stones and urothelial cancer, are in high demand. The availability of advanced healthcare infrastructure and increased healthcare spending in the US further supports this growth.
Other regions, such as Europe (notably Germany and the UK) and parts of Asia (particularly China), are also witnessing growing adoption of ureteroscopy devices, driven by healthcare reforms, population aging, and an increasing focus on non-invasive procedures.
North America: United States, Canada
Europe: Germany, UK
Asia: China
Rest of World (ROW)
The ureteroscopy devices market is segmented based on product type and end-user, with flexible ureteroscopes currently holding the largest share. Flexible ureteroscopes, known for their maneuverability and effectiveness in outpatient procedures, are expected to remain the most preferred choice for urological surgeries during the forecast period.
Product Type:
Flexible Ureteroscopes
Semi-Rigid Ureteroscopes
End-User:
Hospitals
Ambulatory Surgical Centers
Others
Hospitals are the largest end-users of ureteroscopy devices, particularly due to the complexity and scale of urological surgeries performed in these settings. With technological advancements in imaging and operating room systems, hospitals are increasingly adopting state-of-the-art ureteroscopy devices to improve patient care and surgical efficiency.
The increasing emphasis on minimally invasive procedures is shaping the market dynamics. Ureteroscopy is widely favored over traditional open surgery due to its ability to provide high efficacy with fewer complications and shorter recovery times. As a result, healthcare providers are investing more in ureteroscopy devices, particularly in specialized hospitals and ambulatory surgical centers.
Additionally, improvements in reimbursement policies in many regions, particularly in the United States, are helping to mitigate some of the cost challenges. As reimbursement frameworks evolve, more healthcare providers are likely to adopt ureteroscopy devices, thus accelerating market growth.
The primary factors contributing to the expanding ureteroscopy devices market are the increasing prevalence of kidney stones (urolithiasis) and ureteral cancer. Kidney stones, affecting millions globally, are a significant contributor to the demand for ureteroscopy procedures. The Centers for Disease Control and Prevention (CDC) estimates that about 2.4% of US adults were diagnosed with kidney disease in 2021, with kidney stones being a major risk factor.
Ureteral cancer, though less common than urolithiasis, is another crucial driver. This malignancy, originating in the ureter, necessitates precise diagnostic and therapeutic interventions, further propelling the demand for advanced ureteroscopy devices. Given the rising incidence of both conditions and the growing focus on non-invasive surgical options, ureteroscopy devices are becoming indispensable in modern urology practices.
A pivotal trend shaping the ureteroscopy devices market is the integration of advanced technologies aimed at enhancing surgical outcomes and patient safety. Notably, innovations such as flexible ureteroscopes, semi-rigid ureteroscopes, and digital ureteroscopes with high-definition imaging are revolutionizing stone removal procedures.
The development of disposable flexible ureteroscopes, which help mitigate risks of cross-contamination, is another key advancement driving market growth. Additionally, integrated systems and hybrid operating rooms, combining advanced imaging and minimally invasive surgical techniques, are enhancing procedural efficiency, reducing recovery time, and improving patient outcomes.
Technological improvements are not only improving the effectiveness of stone removal but are also contributing to the shift toward outpatient-based treatments, thereby making ureteroscopy more accessible to patients.
Despite the favorable growth outlook, the ureteroscopy devices market faces several challenges. One of the key hurdles is the high cost of ureteroscopy devices and associated procedures. The expense of purchasing and maintaining advanced devices, coupled with the costs of procedures, can be prohibitive, particularly in regions with less-developed healthcare systems.
Furthermore, the market is experiencing a shortage of skilled professionals proficient in performing ureteroscopy procedures, which can impact the adoption and effective use of these devices. While technological innovations have addressed some of these challenges, including offering more user-friendly systems, the need for ongoing training and expertise remains crucial.
The ureteroscopy devices market is experiencing significant growth, driven by advancements in minimally invasive procedures for treating kidney stones and other urological disorders. Flexible ureteroscopes and semi-rigid ureteroscopes are crucial tools in endoscopic surgery, particularly for stone removal and ureteral access. The increasing prevalence of kidney stones, renal calculi, and ureteral cancer has led to greater demand for diagnostic imaging and high-definition imaging in ureteroscopy procedures. Laser lithotripsy, using Holmium laser technology, and stone fragmentation with shock wave therapy are commonly employed in the treatment process. Additionally, ureteral stents and basket retrieval systems are vital components in stone management. The market is also seeing a rise in the adoption of single-use scopes and disposable endoscopes, alongside reusable ureteroscopes, to meet sterilization and infection control standards in urologic surgery. Ureteroscope design innovations, particularly in fiber optic and optical systems, are enhancing the surgical precision and durability of medical endoscopes.
Get more details by ordering the complete report
Several prominent companies dominate the ureteroscopy devices market, each striving to expand their market share through product innovations, strategic partnerships, and geographical expansion.
Key players in the market include:
These companies are heavily investing in research and development to introduce new and advanced ureteroscopy solutions, such as flexible ureteroscopes with high-definition imaging and integrated systems for improved procedural outcomes. Strategic mergers, acquisitions, and partnerships are also helping these players extend their market reach and enhance their product portfolios.
Research into the ureteroscopy devices market highlights the growing demand for digital ureteroscopy and the integration of advanced features for improved performance. Ureteroscopy procedures, including percutaneous nephrolithotomy and intracorporeal lithotripsy, are increasingly benefiting from the use of ultrasound guidance, enhancing the precision of the stone removal process. The application of guidewire use and anti-retropulsion techniques further ensures the success of stone fragmentation and retrieval. The market is also seeing a shift towards products designed for infection control and sterilization processes, which are critical in reducing the risk of complications. With a focus on durability and efficient stone management, innovations in ureteral access and the use of ureteral stents are contributing to the effectiveness of treatments for chronic kidney disease, bladder cancer, and ureteral cancer. The rise in disposable endoscopes is improving both patient outcomes and procedural efficiency.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
